Interim Condensed Consolidated Statements of Income (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues:
Net patient revenues	$ 218,647,000	$ 215,351,000	$ 653,240,000	$ 641,845,000
Other revenues	12,634,000	10,035,000	35,397,000	30,850,000
Net operating revenues	231,281,000	225,386,000	688,637,000	672,695,000
Cost and Expenses:
Salaries, wages and benefits	140,403,000	135,136,000	405,491,000	392,766,000
Other operating	58,956,000	56,616,000	177,571,000	173,830,000
Facility rent	10,314,000	10,006,000	30,960,000	29,972,000
Depreciation and amortization	9,998,000	9,273,000	28,847,000	27,442,000
Interest	1,020,000	594,000	2,913,000	1,782,000
Total costs and expenses	220,691,000	211,625,000	645,782,000	625,792,000
Income Before Non–Operating Income	10,590,000	13,761,000	42,855,000	46,903,000
Non–Operating Income	5,091,000	4,550,000	14,789,000	12,902,000
Income Before Income Taxes	15,681,000	18,311,000	57,644,000	59,805,000
Income Tax Provision	(4,571,000)	(5,744,000)	(20,969,000)	(21,638,000)
Net Income	11,110,000	12,567,000	36,675,000	38,167,000
Dividends to Preferred Stockholders		(2,152,000)		(6,487,000)
Net Income Available to Common Stockholders	$ 11,110,000	$ 10,415,000	$ 36,675,000	$ 31,680,000
Earnings Per Common Share:
Basic (in dollars per share)	$ 0.73	$ 0.75	$ 2.42	$ 2.30
Diluted (in dollars per share)	$ 0.73	$ 0.72	$ 2.41	$ 2.21
Basic (in shares)	15,198,696	13,801,245	15,128,728	13,778,705
Diluted (in shares)	15,222,648	14,422,660	15,216,838	14,365,251
Dividends declared to common stockholders per share (in dollars per share)	$ 0.45	$ 0.40	$ 1.30	$ 1.14